Clinical efficacy of milnacipran: Placebo-controlled trials

International Clinical Psychopharmacology

Volumn 11, Issue SUPPL. 4, 1996, Pages 29-33

  Lecrubier, Y ^a   Pletan, Y ^b   Solles, A ^b   Tournoux, A ^b   Magne, V ^b  

^a PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^b INSTITUT DE RECHERCHE PIERRE FABRE   (France)

Author keywords

Dose response; Efficacy; Major depression; Meta analysis; Milnacipran; Placebo response

Indexed keywords

ANTIDEPRESSANT AGENT; MILNACIPRAN; PLACEBO;

CLINICAL TRIAL; CONFERENCE PAPER; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEPRESSION; DRUG EFFICACY; HOSPITALIZATION; HUMAN; MAJOR CLINICAL STUDY; META ANALYSIS; MULTICENTER STUDY; PRIORITY JOURNAL;

EID: 0029851667     PISSN: 02681315     EISSN: None     Source Type: Journal    
DOI: 10.1097/00004850-199609004-00004     Document Type: Conference Paper

References (13)

1. American Psychiatric Association (1987) Diagnostic and Statistical Manual of Mental Disorders, 3rd edn, revised. Washington DC: American Psychiatric Association.
2. Carney MWP, Roth M, Garside RF (1965) The diagnosis of depressive syndromes and the prediction of ECT response. Br J Psychiatry 111:659-674.
3. Clerc GE, Ruimy P, Verdeau-Paillès J (1994) A double-blind comparison of venflaxine and fluoxetine in patients hospitalized for major depression and melancholia. Int Clin Psychopharmacol 9:139-143.
4. Danish University Antidepressant Group (1986) Citalopram: clinical effect profile in comparison with clomipramine. A controlled multicenter study. Psychopharmacology 90:131-138.
5. Danish University Antidepressant Group (1990) Paroxetine: a selective serotonin reuptake inhibitor showing better tolerance, but weaker antidepressant effect than clomipramine in a controlled multicenter study. J Affect Disord 18:289-299.
6. European College of Neuropsychopharmacology (1995) Clinical relevance of response and improvement in psychopharmacology. Eur Neuropsychopharmacology 5:511-533.
7. Hamilton M (1960) A rating scale for depression. J Neurol Neurosurg Psychiatry 23:56-62.
8. Macher JP, Sichel JP, Serre C, Von Frenckell R, Huck JC, Demarez JP (1989) Double-blind placebo-controlled study of milnacipran in hospitalised patients with major depressive disorders. Neuropsychobiology 22:77-82.
9. Montgomery SA, Åsberg M (1979) A new depression scale designed to be sensitive to change. Br J Psychiatry 134:382-389.
10. Moret C, Charveron M, Finberg JPM, Couzinier JP, Briley M (1985) Biochemical profile of milnacipran, a potential fourth generation antidepressant drug. Neuropharmacology 24:1211-1291.
11. Redmond AM, Kelly JP, Leonard BE (1995) The behavioural effects of milnacipran in the olfactory bulbectomised rat model of depression. Med Sci Res 23:533-534.
12. Stenger A, Couzinier JP, Briley M (1987) Psychopharmacology of milnacipran, a new potential antidepressant. Psychopharmacology 91:147-153.
13. United States Department of Health, Education and Welfare (1976) CGI: Clinical Global Impression. In ECDEU Assessment Manual for Psychopharmacology, revised edn. Edited by Guy W. Rockville, Maryland: National Institute of Mental Health; pp 217-222.